Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diastolic dysfunction is associated with cardiac decompensation after transjugular intrahepatic portosystemic shunt in patients with liver cirrhosis.
Schneider H, Berliner D, Stockhoff L, Reincke M, Mauz JB, Meyer B, Bauersachs J, Wedemeyer H, Wacker F, Bettinger D, Hinrichs JB, Maasoumy B. Schneider H, et al. Among authors: maasoumy b. United European Gastroenterol J. 2023 Nov;11(9):837-851. doi: 10.1002/ueg2.12471. Epub 2023 Oct 28. United European Gastroenterol J. 2023. PMID: 37897707 Free PMC article.
Natural history of acute and chronic hepatitis C.
Maasoumy B, Wedemeyer H. Maasoumy B, et al. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12. doi: 10.1016/j.bpg.2012.09.009. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199500 Review.
Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites.
Stockhoff L, Schultalbers M, Tergast TL, Hinrichs JB, Gerbel S, Meine TC, Manns MP, Simon N, Cornberg M, Meyer BC, Maasoumy B. Stockhoff L, et al. Among authors: maasoumy b. PLoS One. 2020 Jun 25;15(6):e0235199. doi: 10.1371/journal.pone.0235199. eCollection 2020. PLoS One. 2020. PMID: 32584874 Free PMC article. Clinical Trial.
Correction to: Transjugular intrahepatic portosystemic shunt placement: portal vein puncture guided by 3D/2D image registration of contrast-enhanced multi-detector computed tomography and fluoroscopy.
Meine TC, Dewald CLA, Becker LS, Mähringer-Kunz A, Maasoumy B, Maschke SK, Kirstein MM, Werncke T, Wacker FK, Meyer BC, Hinrichs JB. Meine TC, et al. Among authors: maasoumy b. Abdom Radiol (NY). 2021 Jan;46(1):398. doi: 10.1007/s00261-020-02617-0. Abdom Radiol (NY). 2021. PMID: 32642854 Free PMC article. No abstract available.
Percutaneous Transsplenic Balloon-Assisted Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Portal Vein Obliteration for Portal Vein Recanalization: Feasibility, Safety and Effectiveness.
Meine TC, Becker LS, Dewald CLA, Maschke SK, Maasoumy B, Jaeckel E, Wedemeyer H, Wacker FK, Meyer BC, Hinrichs JB. Meine TC, et al. Among authors: maasoumy b. Cardiovasc Intervent Radiol. 2022 May;45(5):696-702. doi: 10.1007/s00270-021-03054-2. Epub 2022 Jan 11. Cardiovasc Intervent Radiol. 2022. PMID: 35018502 Free PMC article.
Markers of cell death predict therapy response in patients with cirrhosis and hepatorenal syndrome.
Heinrich S, Austgen T, Castven D, Hess M, Labenz C, Kirstein M, Zimpel C, Stockhoff L, Maasoumy B, Heinrich B, Wedemeyer HH, Galle PR, Binder H, Nguyen-Tat M, Marquardt JU. Heinrich S, et al. Among authors: maasoumy b. United European Gastroenterol J. 2023 Feb;11(1):92-102. doi: 10.1002/ueg2.12337. Epub 2022 Nov 28. United European Gastroenterol J. 2023. PMID: 36441143 Free PMC article.
Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.
Maasoumy B, Port K, Deterding K, Höner Zu Siederdissen C, Markova AA, Rogalska-Taranta M, Manns MP, Wedemeyer H, Cornberg M. Maasoumy B, et al. Eur J Gastroenterol Hepatol. 2014 Aug;26(8):836-45. doi: 10.1097/MEG.0000000000000121. Eur J Gastroenterol Hepatol. 2014. PMID: 24987822 Clinical Trial.
132 results